Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study.
Fangshu GuanLuxin YangYi ChenJimin ShiXiaolu SongXiaoyu LaiYing LuLizhen LiuGuifang OuyangYanmin ZhaoJian YuYang XuJianping LanHuarui FuYi ZhaoXi QiuPanpan ZhuZhen CaiHe HuangYi LuoPublished in: Cancer (2024)
For patients with Ph+ ALL undergoing allo-HSCT in CR1, imatinib prophylaxis achieved long-term outcomes similar to those of dasatinib.